obese drug news
Your Search Returned 24 tagged news reports
Tick Tock Goes the Obesity Clock
Alexandria :: VA :: USA | 2 months ago
Credibility
The corollary to that message is that it's going to be awhile before the biotech is able to launch its obesity drug, Contrave. The Food and Drug Administration made the company run a clinical trial to confirm that there weren't any heart-related
Tags:
DEA Recommendation Provides Positive Momentum for Belviq
Alexandria :: VA :: USA | 5 months ago
Credibility
Jordo is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited. ccording to a report from the Drug Enforcement Administration (DEA), Belviq should be classified as a Schedule
Tags:
This Obesity Drug Hits the Market, but Check Your Expectations
Alexandria :: VA :: USA | 8 months ago
Credibility
Contrave, which isn't even approved yet since it's waiting for safety trial data...The availability was noted on Qsymia's website and in an SEC disclosure...That'll get the job done, but don't expect the same kind of well-oiled machine that a launch
Tags:
Is It Time To Buy Into The Anti-Obesity Drug Hype?
Alexandria :: VA :: USA | 9 months ago
Credibility
Meena is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited. There is high risk in trying to time the biopharmaceutical market. Companies can lose in excess of half their
Tags:
Arena Pharma Poised to Rally on Positive FDA Panel Vote
Zurich :: Switzerland | 1 year ago
Credibility
FDA panel of experts that will make a recommendation on Lorcaserin, Arena's obesity medication. Studying the various social networking, discussion boards, blogs, and news, one can quickly sense two groups of participants: Those who are strongly
Tags:
Vivus Could Surge On Qnexa Approval
Alexandria :: VA :: USA | 1 year ago
Credibility
FDA approval allows pharmaceutical and biotech companies to manufacture and sell drug treatments in the United States. Without approval, companies cannot sell or distribute treatments legally. Depending on the complexity of a drug, the number of
Tags:
FDA will take 3 more months to review Vivus drug
Mountain View :: CA :: USA | 1 year ago
Credibility
Calif. (AP) — Drug developer Vivus Inc. says that regulators will take another three months to review the safety strategy on its proposed obesity drug Qnexa. The company says the Food and Drug Administration is now expected to
Tags:
Clamor for obesity pill may test FDA limits
New York City :: NY :: USA | 1 year ago
Credibility
Reuters U.S. drug regulators may have a hard time stopping millions of overweight Americans from taking a new obesity drug that many are likely to view as a miracle pill for slimming waistlines, despite its safety risks. Regulators and doctors are
Tags:
This Biotech's Obese To-Do List Is Done
Alexandria :: VA :: USA | over 1 year ago
Credibility
Ever offer to pay 6% more for your ticket because the plane was on time?...Arena has been guiding for a resubmission "around the end of the year."...Presumably the company waited until yesterday to announce the submission to make sure more investors
Tags:
Working Through the Obese To-Do List in 2011
Alexandria :: VA :: USA | over 1 year ago
Credibility
Food and Drug Administration adding to its to-do list of required actions before the company could resubmit its marketing application for obesity drug lorcaserin. But the development-stage biotech pressed on and looks like it'll end the year ahead of
Tags:
